Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Relypsa, Inc.

Home Clinical Trial Sponsors and OrganizationsRelypsa, Inc.

Relypsa, Inc.

ACTIVE

加利福尼亚州圣马特奥县, California, United Statesrelypsa.comSubsidiary406 employeesEstablished: 2007-10-01

Part of VIFOR PHARMA AG

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

27

20 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2007

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

7

25.9%

Phase 2

5

18.5%

Phase 3

1

3.7%

Phase 4

1

3.7%

Trial Status Distribution

Active, not recruiting

20

74.1%

Completed

6

22.2%

Terminated

1

3.7%

Clinical Trials

Trials sponsored by this organization (27)

A placebo controlled Study of Patiromer for the Management of high potassium serum levels in Subjects Receiving a certain group of medications called Renin-Angiotensin-Aldosterone System Inhibitor for treatment of Heart failure.

Active, not recruiting

Jan 2021878 participants

A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Medications for the Treatment of Heart Failure (DIAMOND) - DIAMOND

Active, not recruiting

Jul 20192,388 participants

A study of Patiromer alongside Spironolactone to control Blood Pressure in patients with Resistant Hypertension (high blood pressure that does not easily respond to medication) and Chronic Kidney Disease.

Active, not recruiting

Jan 2018290 participants

A Clinical Trial to Evaluate the Effectivenes, Safety, and Tolerability of Patiromer for Oral Administration in Children and Adolescents aged 2 to < 18 Years with Chronic Kidney Disease and High Levels of Serum Potassium Concentratio

Active, not recruiting

Jun 201754 participants

A study of Patiromer alongside Spironolactone to control Blood Pressure in patients with Resistant Hypertension (high blood pressure that does not easily respond to medication) and Chronic Kidney Disease.

Active, not recruiting

Jun 2017290 participants

Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease

Jan 2017295 participants

A study of Patiromer alongside Spironolactone to control Blood Pressure in patients with Resistant Hypertension (high blood pressure that does not easily respond to medication) and Chronic Kidney Disease.

Active, not recruiting

Dec 2016290 participants

A study of Patiromer alongside Spironolactone to control Blood Pressure in patients with Resistant Hypertension (high blood pressure that does not easily respond to medication) and Chronic Kidney Disease.

Active, not recruiting

Nov 2016290 participants

Page 1 of 4

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials27
Approvals
News

Back to Organizations